Prognostic Significance of Serum Lactate Dehydrogenase in Osteosarcoma of the Extremity: Experience at Rizzoli on 1421 Patients Treated over the Last 30 Years

Mirra J.M. : Bone tumors, Lea & Febiger, Philadelphia, pp 255–349, London, 1989.

Rosen G. , Marcove R.C. , Caparros B. , Nirenberg A. , Kosloff C. , Huvos A.G. : Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer, 43: 2163–2177, 1979.

Jaffe N. , Robertson R. , Takue Y. , Cangir A. , Wallace S. , Carrasco H. , Eftekhari F. , Ayala A. , Wang A. : Control of primary osteosarcoma with chemotherapy. Cancer, 56: 461–466, 1985.

Winkler K. , Beron G. , Delling G. , Heise U. , Kabisch H. , Purfurst C. , Berger J. , Ritter J. , Jurgens H. , Gerein V. : Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol, 6: 329–337, 1988.

Link M.P. , Goorin A.M. , Miser A.W. , Green A.A. , Pratt C.B. , Belasco J.B. , Pritchard J. , Malpas J.S. , Baker A.R. , Kirkpatrick J.A. : The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremities. N Eng J Med, 314: 1600–1606, 1986.

Sater G. , Alvegard T.A. , Elomaa I. , Stenwig A.E. , Holmstrom T. , Solheim O.P. : Treatment of osteosarcoma of the extremity with T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single agent high-dose methotrexate: a Scandinavian Sarcoma Group study. J Clin Oncol, 9: 1766–1775, 1991.

Benjamin R.S. , Chawla S.P. , Carrasco C.H. , Raymond A.K. , Murray J.A. , Armen T. , Patel S. , Wallace S. , Ayala A. , Papadopoulos N.E. : Preoperative chemotherapy for osteosarcoma with intravenous doxorubicin and intra-arterial cis-platinum. Ann Oncol, 2: 3–6, 1992.

Provisor A.J. , Ettinger L.J. , Nachman JB , Krailo M.D. , Makley J.T. , Yunis E.J. , Huvos A.G. , Betcher D.L. , Baum E.S. , Kisker C.T. , Miser J.S. : Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol, 15: 76–84, 1997.

Fuchs N. , Bielack S.S. , Epler D. , Bieling P. , Delling G. , Korholz D. , Graf N. , Heise U. , Jurgens H. , Kotz R. , Salzer-Kuntschik M. , Weinel P. , Werner M. , Winkler K. : Long-term results of the cooperative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol, 9: 893–899, 1998.

Bielack S.S. , Kempf-Bielack B. , Delling G. : Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocol. J Clin Oncol, 20: 776–790, 2002.

Dispersio L. , Kyriazis A.P. , Michael J.G. : Monitoring the therapy of human tumor xenografts in nude mice by the use of lactate dehydrogenase. J Natl Cancer Int, 62: 375–379, 1979.

Nakamura T. , Kitagawat A. : Anticancer drug screen test with LDH in nude mouse bearing bone and soft part sarcoma. Cancer, 56: 1122–1116, 1985

Bierman H.R. , Hill B.R. , Reimbrardt L. : Correlation of lactic dehydrogenase activity with the clinical status of patients with cancer, lymphoma and leukemia. Cancer Res, 17: 660–667, 1957.

Lippert M.C. , Javadpour N. : Lactic dehydrogenase in the monitoring and prognosis of testicular cancer. Cancer, 46: 352–354, 1981.

Brereton D.H. , Simon R. , Pomeroy T.C. : Pretreatment serum lactate dehydrogenase predicting metastatic spread in Ewing's sarcoma. Ann Intern Med, 83: 352–354, 1975.

Bacci G. , Ferrari S. , Longhi A. , Rimondini S. , Versari M. , Zanone A. , Forni C. : Prognostic significance of serum LDH in Ewing's sarcoma of bone. Oncol Rep, 6: 807–811, 1999.

Bacci G. , Ferrari S. , Sangiorgi L. , Picci P. , Casadei R. , Orlandi M. , Intorno D. , Battistini A. , Zanone A. : Prognostic significance of serum lactate dehydrogenase in patients with osteosarcoma of the extremities. J Chemother, 6: 204–210, 1994.

Meyers P.A. , Heller G. , Healey J. , Huvos A. , Lane J. , Marcove R. , Applewhite A. , Vlamis V. , Rosen G. : Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol, 10: 5–15, 1992.

Meyers P.A. , Heller G. , Vlamis V. : Osteosarcoma of the extremities: chemotherapy experience at the Memorial Sloan-Kettering. In: Osteosarcoma in adolescents and young adults, Bennett H.G. (Ed), pp 309–311, Kluwer Academic, Boston, 1993.

Link M.P. : The multi-institutional osteosarcoma study: an update. In: Osteosarcoma in adolescents and young adults, Bennett H.G. (Ed), pp 107–112, Kluwer Academic, Boston, 1993.

Enneking W.F. , Spanier S. , Goodman M.A. : A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop, 153: 106–120, 1980.

Picci P. , Bacci G. , Campanacci M. , Gasparini M. , Pilotti S. , Cerasoli S. , Bertoni F. , Guerra A. , Capanna R. , Albisinni U. : Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor. Cancer, 56: 1515–1521, 1985.

Campanacci M. , Bacci G. , Bertoni F. , Picci P. , Minutillo A. , Franceschi C. : The treatment of osteosarcoma of the extremities: twenty years experience at the Istituto Ortopedico Rizzoli. Cancer, 48: 1569–1581, 1981.

Bacci G. , Gherlinzoni F. , Picci P. , Van Horn J.R. , Jaffe N. , Guerra A. , Ruggieri P. , Biagini R. , Capanna R. , Toni A. : Adriamycinmethotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study. Eur J Cancer Clin Oncol, 22: 1337–1345, 1986.

Bacci G. , Picci P. , Ruggieri P. , Mercuri M. , Avella M. , Capanna R. , Brach Del Prever A. , Mancini A. , Gherlinzoni F. , Padovani G. : Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin. Cancer, 65: 2539–2553, 1990.

Bacci G. , Picci P. , Ferrari S. , Ruggieri P. , Casadei R. , Tienghi A. , Brach del Prever A. , Gherlinzoni F. , Mercuri M. , Monti C. : Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer, 72: 3227–3238, 1993.

Bacci G. , Picci P. , Ferrari S. , Casadei R. , Brach Del Prever A. , Tienghi A. , Mancini A. : Influence of adriamycin dose in the outcome of patients with osteosarcoma treated with multidrug neoadjuvant chemotherapy: results of two sequential studies. J Chemother, 5: 237–246, 1993.

Bacci G. , Briccoli A. , Ferrari S. , Longhi A. , Mercuri M. , Capanna R. , Donati D. , Lari S. , Forni C. , DePaolis M. : Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Eur J Cancer, 37: 2030–2039, 2001.

Bacci G. , Ferrari S. , Longhi A. , Picci P. , Mercuri M. , Alvegard T.A. , Saeter G. , Donati D. , Manfrini M. , Lari S. , Briccoli A. , Forni C. : High dose ifosfamide in combination with high dose methotrexate, doxorubicin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study. J Chemother, 14: 198–206, 2002.

Lorentz K. , Klauke R. , Schmidt E. : Recommendation for the determination of the catalytic concentration of lactate dehydrogenase at 37 degrees C. Standardization Committee of the German Society for Clinical Chemistry, Enzyme Working Group of the German Society for Clinical Chemistry. Eur J Clin Chem Clin Biochem, 31: 897–899, 1993.

Davis A.M. , Bell R.S. , Goodwin P.J. : Prognostic factors in osteosarcoma: a critical review. J Clin Oncol, 12: 423–31, 1994.

McKenna R.J. , Schwin C.P. , Soong K.J. : Sarcomata of osteogenic series: analysis of 552 cases. J Bone Joint Surg, 48: 126, 1966.

Lockshin M. , Higgins I. : Prognosis in osteogenic sarcoma. Clin Orthop, 58: 85–103, 1968.

Thorpe W. , Reilly J. , Rosemberg S. : Prognostic significance of alkaline phosphatase measurement in patients with osteogenic sarcoma receiving chemotherapy. Cancer, 43: 2178–2181, 1979.

Bacci G. , Longhi A. , Ferrari S. , Lari S. , Manfrini M. , Donati D. , Forni C. , Versati M. : Prognostic significance of serum alkaline phosphatase in osteosarcoma of the extremity treated with neoadjuvant chemotherapy: recent experience at Rizzoli Institute. Oncol Rep, 9: 171–175, 2002.